Send to

Choose Destination
BMJ. 2019 Jan 23;364:k5432. doi: 10.1136/bmj.k5432.

Three week versus six week immobilisation for stable Weber B type ankle fractures: randomised, multicentre, non-inferiority clinical trial.

Author information

Department of Surgery, Division of Orthopaedic and Trauma Surgery, Oulu University Hospital, Kajaanintie 50, PO Box 21, FI 90029 OYS, Oulu, Finland
Medical Research Centre (MRC) Oulu, Oulu, Finland.
Department of Orthopaedics, Tampere University Hospital, Tampere, Finland.
Department of Surgery, Division of Orthopaedic and Trauma Surgery, Oulu University Hospital, Kajaanintie 50, PO Box 21, FI 90029 OYS, Oulu, Finland.
Division of Operative Care, Oulu University Hospital, Oulu, Finland.
Finnish Centre for Evidence-Based Orthopaedics (FICEBO), Department of Orthopaedics, University of Helsinki, Helsinki, Finland.
Department of Orthopaedics and Traumatology, Helsinki University Hospital, Helsinki, Finland.



To determine whether treatment of isolated stable Weber B type ankle fractures with a cast or a simple orthotic device for three weeks produces non-inferior outcomes compared with conventional immobilisation in a cast for six weeks.


Randomised, pragmatic, non-inferiority, clinical trial with blinded outcome assessment.


Two major trauma centres in Finland, 22 December 2012 to 6 June 2016.


247 skeletally mature patients aged 16 years or older with an isolated Weber B type fibula fracture and congruent ankle mortise in static ankle radiographs.


Participants were randomly allocated to conventional six week cast immobilisation (n=84) or three week treatment either in a cast (n=83) or in a simple orthosis (n=80).


The primary, non-inferiority, intention-to-treat outcome was the Olerud-Molander Ankle Score at 12 months (OMAS; range 0-100; higher scores indicate better outcomes and fewer symptoms). The predefined non-inferiority margin for the primary outcome was -8.8 points. Secondary outcomes were ankle function, pain, quality of life, ankle motion, and radiographic outcome. Follow-up assessments were performed at 6, 12, and 52 weeks.


212 of 247 randomised participants (86%) completed the study. At 52 weeks, the mean OMAS was 87.6 (SD 18.3) in the six week cast group, 91.7 (SD 12.9) in the three week cast group, and 89.8 (SD 18.4) in the three week orthosis group. The between group difference at 52 weeks for the three week cast versus six week cast was 3.6 points (95% confidence interval -1.9 to 9.1, P=0.20), and for the three week orthosis versus six week cast was 1.7 points (-4.0 to 7.3, P=0.56). In both comparisons, the confidence intervals did not include the predefined inferiority margin of -8.8 points. The only statistically significant between group differences observed in the secondary outcomes and harms in the two primary comparisons were slight improvement in ankle plantar flexion and incidence of deep vein thrombosis, both in the three week orthosis group versus six week cast group.


Immobilisation for three weeks with a cast or orthosis was non-inferior to conventional cast immobilisation for six weeks in the treatment of an isolated stable Weber B type fracture.


Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at and declare: TJ reports an honorarium for a lecture on osteoporosis from AMGEN (donated to AllTrials campaign). Other authors declare no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center